Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXC™ and GalXC-Plus™ RNAi technologies, we discover and develop innovativ...
Use this information to figure out if this company is an ideal customer for you.
617.621.8097
75 Hayden Avenue
Lexington, 02421
201 - 500 Employees
$1M - $5M
linkedin.com/company/dicerna-pharmaceuticals-inc.
The most common Dicerna Pharmaceuticals Inc. email format is [f][last] (ex. jdoe@novonordisk-us.com), currently being used by 36% of Dicerna Pharmaceuticals Inc. business email addresses. There are 36 email formats used by Dicerna Pharmaceuticals Inc..
Dicerna Pharmaceuticals Inc.'s CEO is Amanda Tramontozzi
Dicerna Pharmaceuticals Inc.'s HQ is located at 75 Hayden Avenue, Lexington
Dicerna Pharmaceuticals Inc.'s phone number is 617.621.8097
Dicerna Pharmaceuticals Inc.'s official website is novonordisk-us.com
Dicerna Pharmaceuticals Inc.'s revenue is $1M - $5M
Dicerna Pharmaceuticals Inc. has 201 - 500 employees
Dicerna Pharmaceuticals Inc. is in the industry of: Pharmaceuticals
